Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06492174 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

Study acronym: AGENT IDE
StatusActive, Not Recruiting
PhasePhase 3
Started2024-10-07
View on ClinicalTrials.gov ↗

Amendment history

2026-08-20
7 amendments v20-v26
7 re-verifications since 2026-02-18, no change to tracked fields
2026-01-15
Study Status v19
Primary completion dateestimated 2025-12→confirmed 2025-12-19
2025-11-14
8 amendments v11-v18
8 re-verifications since 2025-04-21, no change to tracked fields
2025-03-24
Study Status, Contacts/Locations v10
Study sites26→11
2025-02-26
Study Status v9
Re-verified, no change to tracked fields
Show 8 earlier versions
2025-01-06
Recruiting→Active, Not Recruiting Study Status, Study Design, Contacts/Locations v8
Trial statusRecruiting→Active, Not Recruiting
Study sitesdetails revised at 26 of 26 sites
2024-12-18
Study Status v7
Primary completion date2025-11→2025-12
Completion date2027-11→2027-12
2024-11-21
Study Status, Contacts/Locations v6
Study sites25→26
2024-10-23
Study Status, Contacts/Locations v5
Primary completion date2025-10→2025-11
Completion date2027-10→2027-11
Start dateestimated 2024-10→confirmed 2024-10-07
Study sites19→25
2024-09-30
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start date2024-09→2024-10
Study sitesdetails revised at 19 of 19 sites
2024-09-19
Study Status, Contacts/Locations v3
Study sites12→19
2024-08-22
Study Status, Contacts/Locations v2
Start date2024-08→2024-09
Study sites8→12
2024-08-06
Study Status, Contacts/Locations v1
Start date2024-07→2024-08
Study sites0→8
2024-07-01
Original filing
The purpose of the AGENT IDE study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 36 mm in length (by visual estimate) in a native coronary artery 2.0 mm to 4.0 mm in diameter.
Trial Details
NCT Number NCT06492174
Lead Sponsor Boston Scientific Corporation
Conditions In-Stent Restenosis
Enrollment 20 participants
Start Date 2024-10-07
Primary Completion 2025-12-19 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-17